Dr. Erich Hunziker is co-founder and Chairman of the Board of LamKap Bio group. He is also Chairman of the Board of Directors of BB Biotech AG. He previously served as CFO of Roche from 2001 to 2010. From 1983 to 2001 he held various executive positions at Corange, Boehringer Mannheim and at Diethelm-Keller-Group (DKSH), where he ultimately served as CEO.
In 2013 he was the seed investor to support EngMab AG, which successfully developed a BCMA-bispecific antibody. EngMab was sold to Celgene in 2016.
Dr. Erich Hunziker is Chairman of Entsia International AG and since July 2019 Chairman of NovImmune/Light Chain Bioscience.
He earned a Ph.D. in Industrial Engineering from the Swiss Federal Institute of Technology in Zurich.
